| dc.creator |
Dogan, Aysegul |
|
| dc.creator |
Demirci, Selami |
|
| dc.creator |
Telci, Dilek |
|
| dc.creator |
CANIKYAN, Serli |
|
| dc.creator |
KONGUR, Merve |
|
| dc.creator |
DEDE, Bülent |
|
| dc.creator |
Sahin, Fikrettin |
|
| dc.date |
2018-01-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:50:05Z |
|
| dc.date.available |
2020-10-06T09:50:05Z |
|
| dc.identifier |
4c804add-eafa-4d96-b486-700dfe5177ca |
|
| dc.identifier |
10.1007/s11255-017-1782-9 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/4c804add-eafa-4d96-b486-700dfe5177ca/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/59541 |
|
| dc.description |
Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer |
|
| dc.type |
info:eu-repo/semantics/article |
|